Liver cancer in severe alpha-1 antitrypsin deficiency: who is at risk?
Eur Respir J
.
2022 Nov 3;60(5):2200718.
doi: 10.1183/13993003.00718-2022.
Print 2022 Nov.
Authors
Malin Fromme
1
,
Pavel Strnad
2
Affiliations
1
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
2
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany pstrnad@ukaachen.de.
PMID:
35595316
DOI:
10.1183/13993003.00718-2022
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Liver Neoplasms* / epidemiology
Liver Neoplasms* / etiology
alpha 1-Antitrypsin Deficiency* / complications
alpha 1-Antitrypsin Deficiency* / epidemiology